Highlights Bio-Rad Laboratories, Inc. Deutsche Boerse AG

Stocks

BUWA

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 22:55:02 18/09/2026 +03			5-day change	1st Jan Change
327.40 ^EUR	-1.62%		+2.83%	+27.99%

09-09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM
08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT

Highlights

08-05	Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls	MT
08-05	Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of 2026	CI
08-04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M	MT
08-04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75	MT
08-04	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
08-04	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-01	Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises	MT
04-30	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q1 Revenue $592.1M, vs. FactSet Est of $589.9M	MT
04-30	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q1 Adjusted EPS $1.89 per Share, vs. FactSet Est of $1.97	MT
04-30	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
04-30	Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-13	Bio-Rad Laboratories Q4 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours	MT
02-13	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M	MT
02-13	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q4 Adjusted EPS $2.51 per Share, vs. FactSet Est of $2.71	MT
02-13	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
02-13	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
30/10/25	Bio-Rad Laboratories Q3 Non-GAAP Earnings, Revenue Rise	MT
29/10/25	Bio-Rad Q3 profit beats estimates helped by cost management	RE
29/10/25	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q3 Revenue $653.0M, vs. FactSet Est of $652.2M	MT
29/10/25	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q3 Adjusted EPS $2.26 per Share, vs. FactSet Est of $1.95	MT
29/10/25	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
29/10/25	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
17/10/25	Bio-Rad to report third quarter 2025 financial results	RE
01/08/25	Bio-Rad Laboratories Shares Rise After Price Target Boosts Post-Q2 Beat	MT
01/08/25	Bio-Rad Laboratories Q2 Tops Estimates; Updates Guidance	MT